Klogene Therapeutics, Inc. Company

Prevention and treatment of age related diseases
Technology: Immunotherapy
Industry: Geroscience
Headquarters: Boston, Massachusetts, United States
Founded Date: 2015-01-01
Employees Number: 11-50
Funding Status: Seed
Investors Number: 8
Total Funding: 1800000
Estimated Revenue: $1M to $10M
Last Funding Type: Pre-Seed

Visit Website
mabraham@klogene.com
Register and Claim Ownership